NSE - Delayed Quote • INR
Sharon Bio-Medicine Ltd. (SHARONBIO.NS)
At close: June 28 at 3:59 PM GMT+5:30
Loading Chart for SHARONBIO.NS
DELL
- Previous Close
3.3000 - Open
3.3000 - Bid --
- Ask --
- Day's Range
3.3000 - 33.0000 - 52 Week Range
3.3000 - 33.0000 - Volume
8,834 - Avg. Volume
0 - Market Cap (intraday)
38.178M - Beta (5Y Monthly) --
- PE Ratio (TTM)
1.03 - EPS (TTM)
-- - Earnings Date Feb 21, 2024 - Feb 22, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Related News
Performance Overview: SHARONBIO.NS
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
SHARONBIO.NS
90.00%
S&P BSE SENSEX
2.91%
1-Year Return
SHARONBIO.NS
90.00%
S&P BSE SENSEX
23.78%
3-Year Return
SHARONBIO.NS
90.00%
S&P BSE SENSEX
55.27%
5-Year Return
SHARONBIO.NS
90.00%
S&P BSE SENSEX
90.35%
Compare To: SHARONBIO.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
3.3000
0.00%
Mkt Cap INR 38.178M
Industry Drug Manufacturers—Specialty & Generic
5,332.25
+0.90%
Mkt Cap INR 133.306B
Industry Drug Manufacturers—Specialty & Generic
1,103.40
+1.78%
Mkt Cap INR 646.525B
Industry Drug Manufacturers—Specialty & Generic
76.25
-0.13%
Mkt Cap INR 5.628B
Industry Drug Manufacturers—Specialty & Generic
67.40
-0.15%
Mkt Cap INR 22.255B
Industry Drug Manufacturers—Specialty & Generic
124.95
-0.87%
Mkt Cap INR 31.173B
Industry Drug Manufacturers—Specialty & Generic
1,594.40
+0.91%
Mkt Cap INR 726.672B
Industry Drug Manufacturers—Specialty & Generic
Statistics: SHARONBIO.NS
Valuation Measures
As of 2/25/2024
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
0.20
Enterprise Value/EBITDA
1.28
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--
Company Insights: SHARONBIO.NS
SHARONBIO.NS does not have Company Insights